UNIVERSITY OF COLORADO SOUTHWEST ONCOLOGY GROUP

描述（改编自申请人的摘要）： 科罗拉多癌症中心要求继续支持他们的 西南肿瘤组（SWOG） 联合国的使命 自成立以来，科罗拉多大学癌症中心一直是 通过基础实验室研究降低癌症死亡率， 通过转化研究将科学发现应用于临床， 临床试验的设计、执行和分析。 他们参与 SWOG一直是科罗拉多大学使命的一个组成部分 癌症中心 在哥伦比亚大学进行的机构试点研究 科罗拉多已被带到本集团的形式， 随机试验 来自科罗拉多大学的SWOG成员 继续为行政、教育和科学 SWOG的功能。 科罗拉多大学SWOG成员是椅子或 以下委员会的联合主席：泌尿生殖科（E.大卫 克劳福德），血液和骨髓移植（伊丽莎白Shpall博士），GU 病理学（加里米勒博士）和肺生物学（威尔伯富兰克林）。 斯科特博士 Bearman是SWOG的首席研究员，并担任 州长们 除了这些行政捐款外， 科罗拉多癌症中心的成员是17名协调员或共同协调员。 在上一个授权期间激活的SWOG协议的百分比。 目前，科罗拉多大学的成员是重要的贡献者， 血液和骨髓移植、乳腺、肺和GU委员会。 期间 未来五年，他们预计将继续使重要的科学和 对这些委员会的行政贡献。 此外，他们预计， 在其他领域也做出贡献，包括放射治疗（Rachel博士 Rabinovitch和Michael Weil），发育治疗学（Andrew博士 卡夫）、神经肿瘤学（Bertrand Liang博士）和癌症控制（玛丽博士 Wood）。 他们为我们对西南肿瘤组的贡献感到自豪 并致力于其使命。 他们希望他们的贡献， 在未来五年内增加。

Description (Adapted from the applicant s abstract): The University of Colorado Cancer Center is requesting continuing support for their participation in the Southwest Oncology Group (SWOG). The mission of the University of Colorado Cancer Center has, since it's founding, been the reduction of cancer mortality through basic laboratory research, moving scientific discoveries to the clinic through translational research, and the design, execution, and analysis of clinical trials. Their participation in SWOG has been an integral part of the mission of the University of Colorado Cancer Center. Institutional pilot studies conducted at the University of Colorado have been brought to the Group in the form of prospective randomized trials. SWOG members from the University of Colorado have and continue to contribute to the administrative, educational and scientific functions of SWOG. University of Colorado SWOG members are chairs or co-chairs of the following committees: Genitourinary (Dr. E. David Crawford), Blood and Marrow Transplantation (Dr. Elizabeth Shpall), GU Pathology (Dr. Gary Miller), and Lung Biology (Wilbur Franklin). Dr. Scott Bearman is Principal Investigator for SWOG and sits on the Board of Governors. In addition to these administrative contributions, University of Colorado Cancer Center members are coordinators or co-coordinators of 17 percent of the SWOG protocols activated during the previous grant period. Presently, University of Colorado members are important contributors to the Blood and Marrow Transplantation, Breast, Lung, and GU Committees. During the next five years they expect to continue to make important scientific and administrative contributions to those committees. In addition, they expect to contribute in other areas as well, including radiotherapy (Drs. Rachel Rabinovitch and Michael Weil), developmental therapeutics (Dr. Andrew Kraft), neuro-oncology (Dr. Bertrand Liang) and Cancer Control (Dr. Marie Wood). They are proud of our contributions to the Southwest Oncology Group and are committed to its mission. They expect their contributions to increase during the next 5 years.